ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is JCR Pharmaceuticals Co., Ltd. ?
1
The company declared negative results in Jun'26 after flat results in Mar'26
- DEBT-EQUITY RATIO (HY) Highest at 102.46 %
- CASH AND EQV(HY) Lowest at JPY 23,668 MM
- INVENTORY TURNOVER RATIO(HY) Lowest at 0.43 times
2
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -19.87% returns in the last 1 year, the stock has also underperformed Japan Nikkei 225 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is JCR Pharmaceuticals Co., Ltd. for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
JCR Pharmaceuticals Co., Ltd.
-19.72%
-0.29
41.83%
Japan Nikkei 225
58.07%
2.05
29.37%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.52%
EBIT Growth (5y)
-201.95%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
3.74
Net Debt to Equity (avg)
0.53
Sales to Capital Employed (avg)
0.43
Tax Ratio
31.55%
Dividend Payout Ratio
111.98%
Pledged Shares
0
Institutional Holding
0.01%
ROCE (avg)
14.69%
ROE (avg)
13.01%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.25
EV to EBIT
-17.04
EV to EBITDA
-35.30
EV to Capital Employed
1.14
EV to Sales
2.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-6.67%
ROE (Latest)
-6.89%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Mildly Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bearish
Mildly Bearish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend7What is working for the Company
NET SALES(HY)
At JPY 19,666 MM has Grown at 24.78%
NET PROFIT(HY)
Higher at JPY -1,508 MM
RAW MATERIAL COST(Y)
Fallen by -6.7% (YoY
-26What is not working for the Company
DEBT-EQUITY RATIO
(HY)
Highest at 102.46 %
CASH AND EQV(HY)
Lowest at JPY 23,668 MM
INVENTORY TURNOVER RATIO(HY)
Lowest at 0.43 times
INTEREST(Q)
Highest at JPY 157 MM
OPERATING PROFIT(Q)
Lowest at JPY -1,586 MM
OPERATING PROFIT MARGIN(Q)
Lowest at -16.35 %
PRE-TAX PROFIT(Q)
Lowest at JPY -2,084 MM
NET PROFIT(Q)
Lowest at JPY -1,908 MM
EPS(Q)
Lowest at JPY -15.63
Here's what is working for JCR Pharmaceuticals Co., Ltd.
Net Sales
At JPY 19,666 MM has Grown at 24.78%
Year on Year (YoY)MOJO Watch
Near term sales trend is positive
Net Sales (JPY MM)
Raw Material Cost
Fallen by -6.7% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for JCR Pharmaceuticals Co., Ltd.
Pre-Tax Profit
At JPY -2,084 MM has Fallen at -698.85%
over average net sales of the previous four periods of JPY 348 MMMOJO Watch
Near term Pre-Tax Profit trend is very negative
Pre-Tax Profit (JPY MM)
Net Profit
At JPY -1,908 MM has Fallen at -651.64%
over average net sales of the previous four periods of JPY 345.88 MMMOJO Watch
Near term Net Profit trend is very negative
Net Profit (JPY MM)
Interest
At JPY 157 MM has Grown at 74.44%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Debt-Equity Ratio
Highest at 102.46 % and Grown
In each half year in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Interest
Highest at JPY 157 MM
in the last five periods and Increased by 74.44% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (JPY MM)
Operating Profit
Lowest at JPY -1,586 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (JPY MM)
Operating Profit Margin
Lowest at -16.35 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at JPY -2,084 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (JPY MM)
Net Profit
Lowest at JPY -1,908 MM
in the last five periodsMOJO Watch
Near term Net Profit trend is negative
Net Profit (JPY MM)
EPS
Lowest at JPY -15.63
in the last five periodsMOJO Watch
Declining profitability; company has created lower earnings for shareholders
EPS (JPY)
Cash and Eqv
Lowest at JPY 23,668 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Inventory Turnover Ratio
Lowest at 0.43 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
